Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-17

Clinical Trial Update: To Evaluate Safety of Oral Cholera Vaccine Hillchol® (BBV131) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the safety of the oral cholera vaccine Hillchol (BBV131).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hillchol (BBV131)

Snippet

Sponsor: Bharat Biotech International Limited | Conditions: Cholera | Phase 3 | Status: UNKNOWN